Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A renewed check-up marketed as an possibility to a mammogram for teat cancer detection is not an moving screening TOOL, US health officials say. With the nipple aspirate test, a chest quiz collects fluid from a woman's nipple. The solution is then examined for unconventional and potentially cancerous cells vigrxplus.top. The investigation is advertised as easier, more comfortable and less painful than mammograms.

However, there is no tough to support claims that the test can identify breast cancer, said Dr David Lerner, a medical cop at the US Food and Drug Administration and a mamma imaging specialist. "FDA's involved with is that the nipple aspirate examine is being touted as a standalone tool to screen for and name breast cancer as an alternative to mammography," Lerner said in an intercession news release.

So "Our fearfulness is that women will forgo a mammogram and have this assay instead". Skipping a mammogram could put a woman's strength and life at risk if breast cancer goes undetected, Lerner warned. He said there is no orderly suggestion that the nipple aspirate test, when cast-off on its own, is an effective screening tool for heart cancer or any other medical condition.

The test is still being intentional to determine if it might be useful in combination with other methods to motion pictures for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of bust cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate probe - called the ForeCYTE Breast Health Test - off the supermarket after being warned by the FDA that its claims about the evaluate were unsubstantiated. The caller claimed the study was "literally a Pap defamation for core cancer". Pap smears are a regulatory check for cervical cancer.

And Women who have had a nipple aspirate examination as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should bunk to their drug about whether additional tests are needed, the FDA said. One in eight US women will strengthen bosom cancer in her lifetime whatsapp. The disability is the second important cancer killer of women in the country.